NCT02964078 2026-02-10Interleukin-2 and Pembrolizumab for Metastatic Kidney CancerH. Lee Moffitt Cancer Center and Research InstitutePhase 2 Completed27 enrolled 10 charts
NCT04385654 2020-05-13Toripalimab Combined With Axitinib as Neoadjuvant Therapy for Advanced/Metastatic Non-clear Cell Renal Cell CarcinomaWest China HospitalPhase 2 Unknown40 enrolled